Ikarian Capital, LLC

Holdings History for Avalo Therapeutics, Inc. - Class A Common Stock (AVTX)

Symbol: AVTX on Nasdaq
Investment type: Equity / Class A Common Stock
Latest Disclosed Shares Owned: 711,967 shares
Security Ownership %: 3.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Ikarian Capital, LLC ownership in Avalo Therapeutics, Inc. Class A Common Stock (AVTX)

14 Nov 2025 - Ikarian Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 711,967 shares of Avalo Therapeutics, Inc. Class A Common Stock (AVTX). This represents 3.8% ownership of the company. In their previous filing dated 15 May 2025, Ikarian Capital, LLC had reported owning 1,191,957 shares, indicating a decrease of +40%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Ikarian Capital, LLC	3.8%	-62%	$9,049,101	711,967	-479,990	-40%	$12.71	13G/A	30 Sep 2025	14 Nov 2025, 18:26
Ikarian Capital, LLC	10%		$5,959,785	1,191,957			$5.00	13G/A	31 Mar 2025	15 May 2025, 17:33

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	0.46%	+0.36%	$2,030,766	159,777	+124,477	+353%	$12.71	Q3 2025
30 Jun 2025	0.06%	-0.27%	$176,147	35,300	-164,700	-82%	$4.99	Q2 2025
31 Mar 2025	0.52%	-2%	$1,602,000	200,000	-770,259		$8.01	Q1 2025
31 Dec 2024	2.1%	-0%	$7,209,024	970,259	-100	-0.01%	$7.43	Q4 2024
30 Sep 2024	2.9%	+2.7%	$9,218,411	970,359	+915,629	+1673%	$9.50	Q3 2024
30 Jun 2024	0.22%	+0.03%	$682,483	54,730	+8,082	+17%	$12.47	Q2 2024
31 Mar 2024	0.28%	+0.28%	$1,014,594	46,648	+46,648	NEW	$21.75	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.